SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 20th, 2024 • BioAtla, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 19, 2024, between BioAtla, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT BIOATLA, INC.Common Stock Purchase Warrant • December 20th, 2024 • BioAtla, Inc. • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June 20, 2025 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on June 20, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioAtla, Inc., a Delaware corporation (the “Company”), up to ______ shares of common stock, par value $0.0001per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
